Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Johnson and Johnson
McKinsey
McKesson
Baxter

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Orvepitant

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Orvepitant?

Orvepitant is an investigational drug.

There have been 8 clinical trials for Orvepitant. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2017.

The most common disease conditions in clinical trials are Disease, Depressive Disorder, Major, and Depressive Disorder. The leading clinical trial sponsors are GlaxoSmithKline, Nerre Therapeutics Ltd., and [disabled in preview].

Recent Clinical Trials for Orvepitant
TitleSponsorPhase
A Pharmacokinetic Study of the Effect of Itraconazole Exposure to Orvepitant in Healthy VolunteersNerre Therapeutics Ltd.Phase 1
A Study of the Efficacy and Safety of Orvepitant in Subjects With Pruritus Associated With Atopic DermatitisNerre Therapeutics Ltd.Phase 2
A Dose-ranging Study of Orvepitant in Patients With Chronic Refractory CoughNerre Therapeutics Ltd.Phase 2

See all Orvepitant clinical trials

Clinical Trial Summary for Orvepitant

Top disease conditions for Orvepitant
Top clinical trial sponsors for Orvepitant

See all Orvepitant clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
McKinsey
Express Scripts
Medtronic
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.